Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.59 |
| ▸ | FAAH | O00519 | 4/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.55 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.53 |
| ▸ | CASP2 | P42575 | 1/20 | 0.51 |
| ▸ | PLD1 | Q13393 | 2/20 | 0.50 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.50 |
| ▸ | NAAA | Q02083 | 1/20 | 0.49 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.47 |
| ▸ | SELP | P16109 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21998652 | 1.00 | KDM4E (0.59) | KDM4EFAAHALDH1A1DNM1CASP2 | |
| SCHEMBL21998654 | 1.00 | KDM4E (0.59) | KDM4EFAAHALDH1A1DNM1CASP2 | |
| SCHEMBL9633481 | 0.98 | KDM4E (0.62) | KDM4EFAAHALDH1A1DNM1CASP2 | |
| SCHEMBL21998740 | 0.98 | KDM4E (0.62) | KDM4EFAAHALDH1A1DNM1CASP2 | |
| SCHEMBL21998662 | 0.98 | KDM4E (0.62) | KDM4EFAAHALDH1A1DNM1CASP2 | |
| SCHEMBL21998674 | 0.98 | KDM4E (0.62) | KDM4EFAAHALDH1A1DNM1CASP2 | |
| SCHEMBL8587735 | 0.98 | KDM4E (0.62) | KDM4EFAAHALDH1A1DNM1CASP2 | |
| SCHEMBL20900504 | 0.98 | KDM4E (0.57) | KDM4EFAAHALDH1A1DNM1CASP2 | |
| SCHEMBL13462681 | 0.93 | ALDH1A1 (0.61) | KDM4EFAAHALDH1A1CASP2OPRD1 | |
| SCHEMBL13661579 | 0.92 | ALDH1A1 (0.64) | KDM4EALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200148937-A1 | INHIBITING HYDROCARBON HYDRATE AGGLOMERATION | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2020-05-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200148937-A1 | INHIBITING HYDROCARBON HYDRATE AGGLOMERATION | H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, AHR, SHH | KDM4E 4414/4885FAAH 376/4885ALDH1A1 2259/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.